Literature DB >> 15966508

Thyroid function differently affects serum cystatin C and creatinine concentrations.

L Manetti1, E Pardini, M Genovesi, A Campomori, L Grasso, L L Morselli, I Lupi, G Pellegrini, L Bartalena, F Bogazzi, E Martino.   

Abstract

Cystatin C (Cys C) is a cysteine protease inhibitor produced at a constant rate by nucleated cells, filtered through the glomerular membrane and reabsorbed by kidney tubular cells. Aim of this cross-sectional and longitudinal study was to assess serum Cys C and creatinine (Crea) concentrations in thyroid dysfunction. One hundred and eighty-one patients, 26 with untreated non-toxic nodular goiter, 58 with hyperthyroidism, 31 on L-T4 suppressive therapy for non-toxic nodular goiter, 35 with short-term hypothyroidism after L-T4 withdrawal to perform whole body scan for thyroid cancer, 11 with long-term hypothyroidism due to chronic autoimmune thyroiditis and 20 patients with mild hypothyroidism were enrolled in the study. Fifty-seven age- and sex-matched normal subjects served as controls. Serum Cys C, Crea, free T4 (FT4), FT3 and TSH were assessed. Thirty hyperthyroid patients and 35 short-term hypothyroid patients were followed prospectively until euthyroidism was reached by methimazole or L-T4 therapy. The cross-sectional study showed that mean serum Crea concentrations were significantly reduced in overt hyperthyroid or subclinical hyperthyroid patients, while it was increased in overt hypothyroid patients, but not in mild hypothyroidism. Conversely, serum Cys C levels were significantly increased in overt hyperthyroid patients compared to controls (p<0.05), and significantly decreased in short-term, long-term and mild hypothyroids (p<0.05, p<0.05, p<0.01, respectively). However, 36 (62%) hyperthyroid patients and 50 (76%) hypothyroid patients had normal serum Cys C values. In the prospective study, restoration of euthyroidism by either methimazole or L-T4 therapy was associated with normalization of mean serum Cys C concentrations. In conclusion, thyroid dysfunction affects serum Cys C concentration, possibly influencing the production rate of the protein. However, the observation that hyper- or hypothyroid patients have normal serum Cys C levels limits its use as a marker of peripheral thyroid hormone effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15966508     DOI: 10.1007/bf03347201

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Cystatin for estimation of glomerular filtration rate?

Authors:  J Deinum; F H Derkx
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

2.  Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism.

Authors:  Vijay Jayagopal; Brian G Keevil; Stephen L Atkin; Paul E Jennings; Eric S Kilpatrick
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

3.  Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction?

Authors:  Jan G den Hollander; Raymond W Wulkan; Mart J Mantel; Arie Berghout
Journal:  Clin Chem       Date:  2003-09       Impact factor: 8.327

4.  Structure and expression of the human cystatin C gene.

Authors:  M Abrahamson; I Olafsson; A Palsdottir; M Ulvsbäck; A Lundwall; O Jensson; A Grubb
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

5.  Impact of thyroid dysfunction on serum cystatin C.

Authors:  Manuel Fricker; Peter Wiesli; Michael Brändle; Beat Schwegler; Christoph Schmid
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

6.  Renal handling of radiolabelled human cystatin C in the rat.

Authors:  O Tenstad; A B Roald; A Grubb; K Aukland
Journal:  Scand J Clin Lab Invest       Date:  1996-08       Impact factor: 1.713

Review 7.  Cystatin C: an improved estimator of glomerular filtration rate?

Authors:  Omar F Laterza; Christopher P Price; Mitchell G Scott
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

8.  Determination of serum cystatin C: biological variation and reference values.

Authors:  M M Galteau; M Guyon; R Gueguen; G Siest
Journal:  Clin Chem Lab Med       Date:  2001-09       Impact factor: 3.694

9.  Serum cystatin C is sensitive to small changes in thyroid function.

Authors:  Peter Wiesli; Beat Schwegler; Giatgen A Spinas; Christoph Schmid
Journal:  Clin Chim Acta       Date:  2003-12       Impact factor: 3.786

10.  Biological variation of cystatin C: implications for the assessment of glomerular filtration rate.

Authors:  B G Keevil; E S Kilpatrick; S P Nichols; P W Maylor
Journal:  Clin Chem       Date:  1998-07       Impact factor: 8.327

View more
  55 in total

Review 1.  Association of cystatin C with adverse outcomes.

Authors:  Magdalena Madero; Mark J Sarnak
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

Review 2.  Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review.

Authors:  Trine Borup Andersen; Anni Eskild-Jensen; Jørgen Frøkiaer; Jens Brøchner-Mortensen
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

3.  Impaired estimated glomerular filtration rate associated with hypothyroidism. Does it really mean an acute renal failure?

Authors:  Dieter Brueckner; Maike Brueckner
Journal:  BMJ Case Rep       Date:  2009-04-03

4.  Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease.

Authors:  Jan A Krikken; Ron T Gansevoort; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

Review 5.  [Clinical implications of the estimated glomerular filtration rate].

Authors:  Christian Weingart; Gerhard H Wirnsberger
Journal:  Z Gerontol Geriatr       Date:  2021-01-26       Impact factor: 1.281

Review 6.  Biomarkers of Drug-Induced Kidney Toxicity.

Authors:  Benjamin R Griffin; Sarah Faubel; Charles L Edelstein
Journal:  Ther Drug Monit       Date:  2019-04       Impact factor: 3.681

Review 7.  The correct renal function evaluation in patients with thyroid dysfunction.

Authors:  Mariadelina Simeoni; Annamaria Cerantonio; Ida Pastore; Rossella Liguori; Marta Greco; Daniela Foti; Elio Gulletta; Antonio Brunetti; Giorgio Fuiano
Journal:  J Endocrinol Invest       Date:  2015-10-28       Impact factor: 4.256

Review 8.  Biomarkers of acute kidney injury.

Authors:  Charles L Edelstein
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

9.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

10.  Development of a beta-trace protein based formula for estimation of glomerular filtration rate.

Authors:  Amina Benlamri; Renisha Nadarajah; Abeer Yasin; Nathalie Lepage; Ajay P Sharma; Guido Filler
Journal:  Pediatr Nephrol       Date:  2009-12-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.